BRAINSTORM CELL THERAPEUTICS INC. short interest in 2023
In 2023, BRAINSTORM CELL THERAPEUTICS INC.'s disclosed short interest ran from 5.39% of shares outstanding on 13 Jan 2023 to 8.59% on 29 Dec 2023, a change of +3.20 percentage points. The year's high was 9.97% on 13 Oct 2023 and its low 5.31% on 31 Jan 2023, averaging 7.48% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.75 days on 15 Aug 2023. Full history: BRAINSTORM CELL THERAPEUTICS INC..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025
2023 in figures
- Start of year
- 5.39% (13 Jan 2023)
- End of year
- 8.59% (29 Dec 2023)
- Change
- +3.20 pp
- High
- 9.97% (13 Oct 2023)
- Low
- 5.31% (31 Jan 2023)
- Average
- 7.48%
- Highest days to cover
- 16.75 (15 Aug 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 5.39% | 6.27 | |
| 31 Jan 2023 | 5.31% | 11.98 | |
| 15 Feb 2023 | 6.28% | 5.25 | |
| 28 Feb 2023 | 6.49% | 16.48 | |
| 15 Mar 2023 | 6.55% | 13.20 | |
| 31 Mar 2023 | 8.45% | 3.78 | 10-K filed, results (8-K) |
| 14 Apr 2023 | 7.98% | 5.12 | |
| 28 Apr 2023 | 8.63% | 11.38 | |
| 15 May 2023 | 7.82% | 13.98 | 10-Q filed, results (8-K) |
| 31 May 2023 | 7.85% | 12.31 | |
| 15 Jun 2023 | 7.42% | 12.65 | |
| 30 Jun 2023 | 7.63% | 10.24 | |
| 14 Jul 2023 | 7.67% | 12.55 | |
| 31 Jul 2023 | 7.24% | 10.80 | |
| 15 Aug 2023 | 5.90% | 16.75 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 7.15% | 12.44 | |
| 15 Sep 2023 | 7.81% | 7.65 | |
| 29 Sep 2023 | 9.86% | 2.03 | |
| 13 Oct 2023 | 9.97% | 1.00 | |
| 31 Oct 2023 | 7.93% | 2.65 | |
| 15 Nov 2023 | 7.70% | 3.65 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 7.15% | 1.00 | |
| 15 Dec 2023 | 6.85% | 1.00 | |
| 29 Dec 2023 | 8.59% | 1.00 |
See also: BRAINSTORM CELL THERAPEUTICS INC.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.